ARCHIVES

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003

NIH Updates Policy On Large Grants

May 10, 1996